EP2661625A4 - DIAGNOSTIC METHODS - Google Patents

DIAGNOSTIC METHODS

Info

Publication number
EP2661625A4
EP2661625A4 EP12732021.6A EP12732021A EP2661625A4 EP 2661625 A4 EP2661625 A4 EP 2661625A4 EP 12732021 A EP12732021 A EP 12732021A EP 2661625 A4 EP2661625 A4 EP 2661625A4
Authority
EP
European Patent Office
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12732021.6A
Other languages
German (de)
French (fr)
Other versions
EP2661625A1 (en
Inventor
Mark Kopnitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeus Scientific Inc
Original Assignee
Zeus Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeus Scientific Inc filed Critical Zeus Scientific Inc
Publication of EP2661625A1 publication Critical patent/EP2661625A1/en
Publication of EP2661625A4 publication Critical patent/EP2661625A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP12732021.6A 2011-01-05 2012-01-04 DIAGNOSTIC METHODS Withdrawn EP2661625A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161429892P 2011-01-05 2011-01-05
US201161524630P 2011-08-17 2011-08-17
PCT/US2012/020234 WO2012094427A1 (en) 2011-01-05 2012-01-04 Diagnostic methods

Publications (2)

Publication Number Publication Date
EP2661625A1 EP2661625A1 (en) 2013-11-13
EP2661625A4 true EP2661625A4 (en) 2014-10-29

Family

ID=46457702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12732021.6A Withdrawn EP2661625A4 (en) 2011-01-05 2012-01-04 DIAGNOSTIC METHODS

Country Status (6)

Country Link
EP (1) EP2661625A4 (en)
JP (1) JP2014501932A (en)
CN (1) CN103460043A (en)
AU (1) AU2012204413A1 (en)
CA (1) CA2860690A1 (en)
WO (1) WO2012094427A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3591406A1 (en) 2018-07-06 2020-01-08 Euroimmun Medizinische Labordiagnostika AG Device and method for antibody detection
EP3591401A1 (en) 2018-07-06 2020-01-08 Euroimmun Medizinische Labordiagnostika AG Method for the automated detection of antibodies in a liquid biological sample using an antigen chip

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60183559A (en) * 1984-02-29 1985-09-19 Otsuka Pharmaceut Co Ltd Method for measuring autoantibody for hepato-cellular membrane antigen
US5518881A (en) * 1993-11-02 1996-05-21 Flinders Medical Centre Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
WO2003048300A2 (en) * 2001-11-30 2003-06-12 Amnis Corporation Methods of identifying cellular target molecules
WO2010030624A1 (en) * 2008-09-09 2010-03-18 Zeus Scientific, Inc. Methods for diagnosis and assessment of autoimmune disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014028A2 (en) * 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
CN1101936C (en) * 2000-08-14 2003-02-19 李永哲 Preparation method of antinuclear antibody detection reagent Hep-2 cell antigen fragment and its product
CN2653510Y (en) * 2003-09-25 2004-11-03 长沙福滋堂生物技术开发有限公司 Anti-nuclear antigen detection cell thin sheet
JP2010510528A (en) * 2006-11-22 2010-04-02 ライフ テクノロジーズ コーポレーション Biomarkers for autoimmune diseases
CN101017168B (en) * 2007-02-15 2012-08-29 广州万孚生物技术股份有限公司 Fluorescence rubber latex quantitative chromatography indicator paper and manufacture method thereof
DE102007052281A1 (en) * 2007-11-02 2009-05-07 Zenteris Gmbh Single-step multiplex immunoassay
JP2011503586A (en) * 2007-11-13 2011-01-27 メディパン・ゲーエムベーハー Method for measuring final antibody titer by indirect immunofluorescence measurement method and evaluation method thereof
US8630690B2 (en) * 2009-05-05 2014-01-14 Electric Power Research Institute, Inc. Thermal contraction compensation for superconducting and cryo-resistive cables
ES2425540T3 (en) * 2010-02-22 2013-10-16 Medipan Gmbh Procedure and device for the simultaneous detection of antibodies bound to synthetic and cellular and / or tissue substrates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60183559A (en) * 1984-02-29 1985-09-19 Otsuka Pharmaceut Co Ltd Method for measuring autoantibody for hepato-cellular membrane antigen
US5518881A (en) * 1993-11-02 1996-05-21 Flinders Medical Centre Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
WO2003048300A2 (en) * 2001-11-30 2003-06-12 Amnis Corporation Methods of identifying cellular target molecules
WO2010030624A1 (en) * 2008-09-09 2010-03-18 Zeus Scientific, Inc. Methods for diagnosis and assessment of autoimmune disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012094427A1 *

Also Published As

Publication number Publication date
JP2014501932A (en) 2014-01-23
AU2012204413A1 (en) 2013-08-15
CN103460043A (en) 2013-12-18
EP2661625A1 (en) 2013-11-13
WO2012094427A1 (en) 2012-07-12
CA2860690A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
EP2685807A4 (en) SCREENING METHODS
DK3467500T3 (en) Cobinder-supported assay methods
DK2649468T3 (en) ultrasonic Measurement
EP2668891A4 (en) ENDOSCOPIC SYSTEM
EP2716490A4 (en) VEHICLE
BR112014002399A2 (en) set
EP2705366A4 (en) Diagnostic device
CO6890075A2 (en) Calibrable breathalyzer
DE112012005067A5 (en) powertrain
EP2783627A4 (en) Diagnostic device
DE112012002790A5 (en) powertrain
EP2735467A4 (en) VEHICLE
BR112014004535A2 (en) vehicle
EP2791653A4 (en) OPTIMIZED DIFFUSOMETRY TECHNIQUES
EP2692275A4 (en) DIAGNOSTIC SYSTEM
BR112014008091A2 (en) Toothbrush
EP2708430A4 (en) VEHICLE
BR112014015685A2 (en) motor
EP2742358A4 (en) CANCER DIAGNOSTIC METHODS
EP2674100A4 (en) ENDOSCOPIC SYSTEM
EP2654196A4 (en) TRANSDUCER
AP2013007084A0 (en) Diagnostic method
IL227295A0 (en) diagnostic method
EP2775735A4 (en) TRANSDUCER
BR112014016060A2 (en) vehicle

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141001

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/50 20060101ALN20140926BHEP

Ipc: G01N 33/564 20060101AFI20140926BHEP

Ipc: G01N 33/53 20060101ALN20140926BHEP

Ipc: G01N 33/543 20060101ALI20140926BHEP

Ipc: G01N 33/68 20060101ALI20140926BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150429